Global COVID-19 Detection Kits Market Size By Type (Nucleic Acid Detection Kit, Antibody Detection Kit), By Application (Hospital, Scientific Research), By Region, And Segment Forecasts, 2023 to 2032

The Global COVID-19 Detection Kits Market was valued at USD 28.4 billion in 2023 and is projected to reach USD 46.9 billion by 2031, expanding at a CAGR of 6.7% over the forecast period (2023–2031). This growth is fueled by ongoing global surveillance efforts, the need for rapid diagnostics in pandemic management, and the increasing demand for point-of-care (POC) and at-home testing solutions. The market includes RT-PCR kits, antigen detection kits, antibody tests, and isothermal nucleic acid amplification-based devices, which continue to play a vital role in early detection, monitoring, and containment of SARS-CoV-2 and its variants.

Drivers:

1. Continued Surveillance and Preparedness Initiatives:

Governments and healthcare organizations across the globe are investing in large-scale testing infrastructure and stockpiling detection kits to prepare for future COVID-19 surges and emerging variants.

2. Advancements in Testing Technologies:

The emergence of highly sensitive, rapid, and non-invasive COVID-19 detection methods—such as CRISPR-based diagnostics and smartphone-integrated biosensors—has broadened testing accessibility and improved diagnostic accuracy.

3. Growth in At-Home and Point-of-Care Testing:

Consumer preference for convenient and private testing has led to the proliferation of self-testing kits and mobile testing platforms, spurring demand across both developed and emerging economies.

Restraints:

1. Declining Testing Volume Post-Pandemic Peak:

With mass vaccination campaigns and reduced hospitalization rates, demand for routine COVID-19 testing has started to plateau, impacting kit manufacturers dependent on high testing volumes.

2. Regulatory and Reimbursement Challenges:

Varying regulatory frameworks and inconsistent reimbursement policies for COVID-19 testing across countries hinder market entry and scalability for emerging companies.

Opportunity:

1. Variant-Specific and Multiplex Testing Kits:

The development of kits that simultaneously detect multiple respiratory pathogens (e.g., influenza, RSV, COVID-19) presents a growing opportunity, particularly during seasonal outbreaks and future pandemics.

2. Expansion in Underserved and Rural Areas:

Emerging economies in Asia-Pacific, Africa, and Latin America present untapped potential, with rising investments in diagnostic infrastructure and growing awareness of infectious disease testing.

Market by System Type Insights:

In 2023, the RT-PCR Kits segment held the largest market share due to its status as the gold standard in COVID-19 detection for accuracy and reliability. However, the Antigen Testing Kits segment is expected to witness the fastest growth, driven by increased deployment in rapid community testing, travel screening, and at-home diagnostics. Antigen kits offer quick results at lower costs, making them ideal for mass testing.

Market by End-Use Insights:

Hospitals and Diagnostic Laboratories dominated the end-use segment in 2023, owing to high-volume centralized testing and confirmatory diagnostics. Meanwhile, the Home Care segment is gaining rapid momentum, supported by FDA-authorized self-test kits and rising consumer awareness. Governments and retailers have collaborated extensively to distribute self-testing kits, especially in North America and Europe.

Market by Regional Insights:

North America led the global COVID-19 Detection Kits Market in 2023, accounting for the largest share due to early adoption of advanced diagnostics, strong public health infrastructure, and large-scale government funding. Asia-Pacific is projected to exhibit the highest growth rate during the forecast period, with countries like China, India, and South Korea investing heavily in diagnostic testing, especially across rural and semi-urban regions.

Competitive Scenario:

Leading players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, Quidel Corporation, Cepheid, and SD Biosensor. These companies are actively engaged in new product launches, mergers, strategic collaborations, and regulatory approvals. For instance:

In 2024, Roche launched a high-throughput multiplex PCR test capable of detecting COVID-19, influenza A/B, and RSV simultaneously.

Abbott expanded its portfolio with a saliva-based antigen self-test approved for use in Europe in 2023.

In 2023, SD Biosensor partnered with the Indian government to provide affordable home-use antigen kits under public health programs.

Scope of Work – Global COVID-19 Detection Kits Market

Report Metric Details

Market Size (2023) USD 28.4 billion

Projected Market Size (2031) USD 46.9 billion

CAGR (2023–2031) 6.7%

Market Segments By System Type (RT-PCR Kits, Antigen Kits, Antibody Kits), By End-Use, Region

Growth Drivers Continuous pandemic preparedness, technology advancements, rise in POC/home testing

Opportunities Variant/multiplex detection, emerging market expansion

Key Market Developments:

March 2024 – Thermo Fisher Scientific announced the global launch of a new rapid PCR platform with results in under 30 minutes, designed for mobile labs and critical response scenarios.

January 2024 – Quidel Corporation secured emergency use authorization (EUA) for its next-generation COVID-19 and Flu Combo at-home test in the U.S.

October 2023 – Bio-Rad Laboratories partnered with African Union's Africa CDC to supply COVID-19 antigen kits to underserved regions.

FAQs:

1) What is the current market size of the Global COVID-19 Detection Kits Market?

The market was valued at USD 28.4 billion in 2023.

2) What is the major growth driver of the Global COVID-19 Detection Kits Market?

Major growth drivers include technological advancements in testing and ongoing pandemic preparedness strategies.

3) Which is the largest region during the forecast period in the Global COVID-19 Detection Kits Market?

North America held the largest market share in 2023, with Asia-Pacific expected to grow the fastest through 2031.

4) Which segment accounted for the largest market share in the Global COVID-19 Detection Kits Market?

The RT-PCR Kits segment accounted for the largest share in 2023.

5) Who are the key market players in the Global COVID-19 Detection Kits Market?

Key players include Abbott Laboratories, Roche, Thermo Fisher Scientific, Siemens Healthineers, and SD Biosensor.

Would you like a visual infographic or chart summarizing this data for presentations?